Instructions for Genferon Light (Taurine, Interferon Alfa 2b) nasal drops 10 ml
English product name
Genferone Light
Release form
nasal drops 10,000 ME+0.8 mg/1 ml: fl 10 ml with drip nozzle
Description Genferon Light:
Nasal drops are transparent, colorless or light yellow.
1 ml
human recombinant interferon alpha-2b* 10,000 IU
taurin 0.8 mg
* The substance "Interferon alpha-2b human recombinant (pchIFN-α2b)" includes auxiliary substances: sodium chloride, sodium trihydrate acetate, acetic acid ice cold, water d/i.
Auxiliary substances:
dihydrate edetata dihydrate - 0.02 mg, glycerol - 7 mg, dextran 35-45 thousand. - 2.4 mg, polysorbate 80 - 1 mg, sodium chloride - 0.8 mg, potassium chloride - 0.02 mg, sodium hydrophosphate - 0.115 mg, sodium dihydrophosphate - 0.02 mg, water d/i - up to 1 ml.
10 ml - bottles of dark glass (1), complete with drip nozzle - packs of cardboard.
ATC codes Genferon Light
L03A Immunostimulators
Clinical-pharmacological groups / Group affiliation
Interferon. Immunomodulating preparation with antiviral action
Active substance
- taurin
- human recombinant interferon alpha-2b
Pharmacotherapy group
Immunomodulatory agent
Storage Conditions
In a dry, light-proof place at 2 to 8°C.
Within the specified shelf life, patients can store the drug after dissection for 7 weeks at a temperature of 2 to 8°C.
Store in a place not accessible to children.
Best before date
The shelf life is two years.
Testimony Genferon Light:
Treatment of influenza and other acute respiratory viral infections in children aged 29 days to 14 years.
Method of use, course and dosage:
At the first sign of the disease, Genferon Light is buried in the nose for five days.
Children from 29 days to eleven months 29 days - one drop in each nasal passage 5 times a day (one dose of 1 000 IU, daily 5 000 IU).
Children from one to three years old - two drops in each nasal passage 3-4 times a day (a single dose of 2 000 IU. daily 6 000-8 000 IU).
Children from 3 to 14 years old - two drops in each nasal passage 4-5 times a day (a single dose of 2 000 IU, daily dose - 8 000-10 000 IU).
Use in children
It is contraindicated to newborns up to 28 days.
- Nosology Genferon Light (ICD codes)
- J06.9
- Acute upper respiratory tract infection unspecified
- J10
- Influenza caused by an identified seasonal influenza virus
Pharmacological effect
The preparation Genferon Light, nasal drops, has an antiviral, immunomodulatory, anti-inflammatory, antiproliferative, antibacterial effect, has local regenerating, membrane stabilizing and antioxidant properties.
